• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Terumo launches peripheral stent in U.S.

Terumo launches peripheral stent in U.S.

June 18, 2015 By Fink Densford

Terumo launches peripheral stent in USTerumo (TYO:4543) said today that it launched the Misago RX self-expanding peripheral stent in the U.S. The announcement was made at the Society for Vascular Surgery’s annual meeting in Chicago.

The stent is designed to treat patients with peripheral artery disease in the superficial femoral artery or proximal popliteal artery, the Tokyo-based company said.

“The Misago stent has a flexible design and good radial force that we found performed well in the superficial femoral artery. Peripheral artery disease can have devastating consequences but we believe the Misago stent offers a durable treatment option for superficial femoral artery disease,” principal investigator Dr. John Fritz Angle said in a press release.

Terumo said it won FDA premarket approval for the device in May, based on 1-year data from a single-arm, multi-center non-randomized prospective clincial trial. The stent had been studied in more than 5000 patients, the company added.

“The lack of differences in outcomes among the patients studied supports the validity of multi-national trials which will streamline approvals in different nations and maximize resources while reducing costs.  I can foresee future trials which build upon our harmonization study design,” chief primary investigator Dr. Takao Ohki said in a press release.

Terumo said that the trial reported a 0.9% rate of stent fracture after 12 months, as well as a 100% success rate in delivery to the lesion site.

“We look forward to partnering with the U.S. interventional medical community to bring the benefits of this novel technology, as well as others in the future, to patients in the U.S. We express our gratitude to all the OSPREY investigators that helped to advance the scientific knowledge of the Misago stent,” Terumo veep of marketing Chris Pearson said.

Filed Under: Stents, Vascular Tagged With: Peripheral, Terumo

More recent news

  • Real-world data backs Route 92 reperfusion system
  • LivsMed unveils new surgical robot with telesurgery capabilities
  • JenaValve enrolls first patient in TAVR for AR study
  • HistoSonics expands insurance coverage for histotripsy treatment
  • Johnson & Johnson MedTech gets updated FDA nod for Varipulse PFA

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy